| 序号 |
产品名称 |
英文名称 |
CAS No. |
型号 |
价格(元) |
|
| 1 |
4-(4,6-二甲氧基-2-均三嗪基)-4-甲基吗啉盐酸盐水合物 |
4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium chloride |
3945-69-5 |
|
面议 |
查看详细 |
| 2 |
三(2-甲氧基乙基)原硼酸酯 |
tris(2-methoxyethyl) orthoborate |
14983-42-7 |
|
面议 |
查看详细 |
| 3 |
1,1-二氟-2-碘代乙烷 |
2-IODO-1,1-DIFLUOROETHANE |
598-39-0 |
|
面议 |
查看详细 |
| 4 |
2-苄氧基-1,3-丙二醇 |
2-BENZYLOXY-1,3-PROPANEDIOL |
14690-00-7 |
|
面议 |
查看详细 |
| 5 |
鲁索利替尼 |
Ruxolitinib |
941678-49-5 |
|
面议 |
查看详细 |
| 6 |
4-氯-7-[[2-(三甲基硅烷基)乙氧基]甲基]-7H-吡咯并[2,3-d]嘧啶 |
4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE |
941685-26-3 |
|
面议 |
查看详细 |
| 7 |
1-(1-乙氧基乙基)-4-吡唑硼酸频哪醇酯 |
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
1029716-44-6 |
|
面议 |
查看详细 |
| 8 |
4-（1H-吡唑-4-基）-7 - （（2-（三甲基硅基）乙氧基）甲基）-7H-吡咯并[2,3-d]嘧啶 |
4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE |
941685-27-4 |
|
面议 |
查看详细 |
| 9 |
3-环戊基丙烯腈 |
3-CYCLOPENTYLACRYLONITRILE |
591769-05-0 |
|
面议 |
查看详细 |
| 10 |
卡格列净 |
Canagliflozin |
842133-18-0 |
|
面议 |
查看详细 |
| 11 |
8-溴-7-(2-丁炔)-3-甲基黄嘌呤 |
8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
666816-98-4 |
|
面议 |
查看详细 |
| 12 |
3,4,5-三-三甲硅氧基-6-三甲基硅氧基甲基-四氢-2H-吡喃-2 - 酮 |
(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one |
32469-28-6 |
|
面议 |
查看详细 |
| 13 |
2-(4-氟苯基)-5-[(5-溴-2-甲基苯基)甲基]噻吩 |
2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene |
1030825-20-7 |
|
面议 |
查看详细 |
| 14 |
2-(2-甲基-5-碘苯甲基)-5-(4-氟苯)噻吩 |
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene |
898566-17-1 |
|
面议 |
查看详细 |
| 15 |
2-{3-[[5-(4-氟苯基)-2-噻吩基]甲基]-4-甲基苯基}-3,4,5-三-三甲硅氧基-6-三甲基硅氧基甲基- |
2-{3-[5-(4-Fluoro-phenyl)-thiophen-2-ylmethyl]-4-methyl-phenyl}-3,4,5-tris-trimethylsilanyloxy-6-trimethylsilanyloxymethyl-tetrahydro-pyran-2-ol |
1132832-76-8 |
|
面议 |
查看详细 |
| 16 |
8-溴-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二 |
8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione |
853029-57-9 |
|
面议 |
查看详细 |
